AUPH icon

Aurinia Pharmaceuticals
AUPH

Overview Fund Activity

64 hedge funds and large institutions have $113M invested in Aurinia Pharmaceuticals in 2018 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 19 increasing their positions, 17 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
64
Holders Change
-4
Holders Change %
-5.88%
% of All Funds
1.47%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
19
Reduced
17
Closed
14
Calls
$595K
Puts
$2.79M
Net Calls
-$2.2M
Net Calls Change
-$73K

Top Buyers

1
BlackRock
1
BlackRock
New York
$5.42M
2
Morgan Stanley
2
Morgan Stanley
New York
$3.15M
3
D.E. Shaw & Co
3
D.E. Shaw & Co
New York
$1.21M
4
PC
4
Polar Capital
United Kingdom
$13M
5
Goldman Sachs
5
Goldman Sachs
New York
$6.45M

Top Sellers

1
O
1
OrbiMed
New York
$3.25M
2
Point72 Asset Management
2
Point72 Asset Management
Connecticut
$0
3
Balyasny Asset Management
3
Balyasny Asset Management
Illinois
$0
4
AIC
4
AWM Investment Company
New York
$0
5
Fidelity Investments
5
Fidelity Investments
Massachusetts
$23.8M
Name Holding Trade Value Shares
Change 		Shares
Change %
CSS
76
Cubist Systematic Strategies
Connecticut
– -$16K -3,472 Closed
CA
77
Calton & Associates
Florida
– -$11K -2,000 Closed
TDC
78
Thompson Davis & Co
Virginia
– -$1K -250 Closed
1 2 3
4